Skip to content

Author

Nandkishor Shingne

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

RETROSPECTIVE STUDY OF EFFICACY AND SAFETY OF THE COMBINATION LINAGLIPTIN, EMPAGLIFLOZIN, METFORMIN IN THE MANAGEMENT OF TYPE 2 DIABETES IN INDIA IN THE REAL-WORLD SETTING

Background: Type 2 diabetes mellitus (T2DM) is a progressive disorder with high cardiovascular (CV) risk, often inadequately controlled on monotherapy. This study aimed to evaluate real-world efficacy, safety, CV outcomes, tolerability and adherence of the empagliflozin, sitagliptin and metformin fixed-dose combination...

Nandkishor Shingne, Masiha Asar, Abdul Lateef Shaikh et al. · 0 citations
Open access Oct 2026

EFFECTIVENESS OF EMPAGLIFLOZIN AND LINAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES: PHYSICIAN INSIGHTS FROM SOUTHERN INDIA

Background: Type 2 diabetes mellitus (T2DM) is a chronic global health burden associated with cardiovascular (CV) and renal complications. This study aimed to evaluate real-world efficacy, cardiometabolic outcomes, and long-term outcomes of the empagliflozin + linagliptin add-on therapy to metformin in T2DM patients. M...

Nandkishor Shingne, Vrunda Patel, Swati Tiwari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.